Main navigation | Main content
Dr. Brian Herman was appointed vice president for research at the University of Minnesota on January 1, 2013. He is responsible for the oversight and administration of an externally funded research program of more than $800 million, which encompasses all five campuses in the U of M system.
Dr. Herman has primary responsibility for the overall vitality of the university-wide research environment, including supporting evolution of new research, maintaining a competitive research infrastructure, developing and managing campus-wide research policies, and overseeing administrative management of all sponsored research activity. He is also responsible for technology commercialization activities and for the administration of regulatory offices associated with research. He holds a faculty appointment in the Department of Biomedical Engineering in the College of Science and Engineering.
Herman received his undergraduate degree in biology from Adelphi University. He received his doctorate from the University of Connecticut Health Science Center and undertook postgraduate training at Harvard Medical School. Following the completion of his postgraduate training, he joined the faculty at the University of North Carolina at Chapel Hill School of Medicine. He assumed the position of professor and chair of the Department of Cellular and Structural Biology at the University of Texas Health Science Center at San Antonio (UTHSCSA) in June 1998. He served in this capacity until October 2004, when he assumed the position of vice president for research at the UTHSCSA.
He is a past recipient of an American Cancer Society Faculty Research Award (1991-1995), the Dozer Fellowship from Ben Gurion University, Israel (1998), and an NIH National Institute on Aging “Method to Extend Research in Time” (MERIT) Award (1994-2004). In 2004, he received the UTHSCSA Presidential Distinguished Scholar Award, and in 2005 received a second NIH National Institute on Aging MERIT Award (2005-2015). He has served on a number of editorial boards and served on multiple NIH and NSF study sections, including a four-year term on the NIH Cell, Development and Function-2 study section, two of which he served as chair of the study section. His research is focused on the role of apoptosis in aging and in particular the role of caspase-2 in the response of aged animals to higher endogenous levels of oxidative stress.